B+
Bull case
15%
Probability
Target price
$1.80
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
PRFX
PRFBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
PRF-110's comparable preclinical analgesic efficacy, potential OcuRing-K Phase II enrollment, and continued DeepSolar product development could improve the development narrative if execution advances.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
DeepSolar commercial-launch progress has not established material revenue or customer conversion.
Momentum
91
Value
46
Sentiment
70
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.10 · Bull $1.80 · Bear $0.55Analysis 2026-07-21; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $12.00
Why
Momentum91 · Δ7d -
Value46 · Δ7d 0.0
Sentiment70 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • DeepSolar commercial-launch progress has not established material revenue or customer conversion.
- • Financing requirements could create substantial dilution or liquidity pressure.
- • The evidence remains preclinical or early clinical-development stage, with no demonstrated revenue traction, clinical efficacy readout, approval, or confirmed financing runway beyond the prior company update.
Catalyst clock
2026-06-25
PRF-110 expanded preclinical benchmark data
Lead driver: Sentiment · See AI snapshot
Momentum
91
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
46
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Sentiment
70
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 91.0 / Value 46.5 / Sentiment 69.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-21. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.10
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
B-
Bear case
40%
Probability
Target price
$0.55
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.95M
Beta
0.60
Shares Out
3.04M
P/E (TTM)
0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.14
Rev YoY
-
EPS YoY
+3.6%
Gross Margin
-4864.7%
Op Margin
-
Net Debt
-$4.14M
Current Ratio
1.78
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data